Immune Pharmaceuticals Raises $11.7M On Private Offering

March 11, 2014 | Israeli company Immune Pharmaceuticals, which develops treatments for inflammatory disease, has raised $11.7 million on Nasdaq. The funds were raised in a private offering held by the company.